The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Open accessAbstract
In high income countries, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). In many low and middle income countries large HCV epidemics have also emerged among PWID populations. The burden of HCV-related liver disease among PWID is increasing, but treatment uptake remains extremely low. There are a number of barriers to care which should be considered and systematically addressed, but should not exclude PWID from HCV treatment. The rapid development of interferon-free direct-acting antiviral (DAA) therapy for HCV infection has brought considerable optimism to the HCV sector, with the realistic hope that therapeutic intervention will soon provide near optimal efficacy with well-tolerated, short duration, all oral regimens. Further, it has been clearly demonstrated that HCV treatment is safe and effective across a broad range of multidisciplinary healthcare settings. Given the burden of HCV-related disease among PWID, strategies to enhance HCV assessment and treatment in this group are urgently needed. These recommendations demonstrate that treatment among PWID is feasible and provide a framework for HCV assessment and
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jir196 · Cited by 313
Smith, D. J., Combellick, J., Jordan, A. E., & Hagan, H. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.07.004 · Cited by 104
Rosenberg, S. D., Drake, R. E., Brunette, M. F., Wolford, G. L., & Marsh, B. J. (2005) · AIDS · doi:10.1097/01.aids.0000192067.94033.aa · Cited by 87
Assessing the Validity of Self-Reported Medication Adherence in Hepatitis C Treatment
Smith, S. R., Wahed, A. S., Kelley, S. S., Conjeevaram, H. S., Robuck, P. R., & Fried, M. W. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k024 · Cited by 57
Cited by
EASL Recommendations on Treatment of Hepatitis C 2016
(2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.001 · Cited by 985
Dore, G. J., Altice, F., Litwin, A. H., Dalgard, O., Gane, E. J., Shibolet, O., Luetkemeyer, A., Nahass, R., Peng, C.-Y., Conway, B., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0816 · Cited by 359
Self-citationBarbosa, C., Fraser, H., Hoerger, T. J., Leib, A., Havens, J. R., Young, A., Kral, A., Page, K., Evans, J., Zibbell, J., et al. (2019) · Addiction · doi:10.1111/add.14731 · Cited by 48
Evon, D. M., Golin, C. E., Ruffin, R., & Fried, M. W. (2017) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2017.03.008 · Cited by 5
Metadata
- Authors
- Grebely, J., Robaeys, G., Bruggmann, P., Aghemo, A., Backmund, M., Bruneau, J., Byrne, J., Dalgard, O., Feld, J. J., Hellard, M., Hickman, M., Kautz, A., Litwin, A., Lloyd, A. R., Mauss, S., Prins, M., Swan, T., Schaefer, M., Taylor, L. E., & Dore, G. J.
- Venue
- International Journal of Drug Policy
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 26
- Issue
- 10
- Pages
- 1028-1038
- ISSN
- 0955-3959 (ISSN-L)
- OpenAlex
- W2167150962
- Cited by
- 194
- References
- 4
- FWCI
- 19.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recommendations for the management of hepatitis C virus infection among people who inject drugs. https://app.cochat.ai/papers/10.1016/j.drugpo.2015.07.005
- The paper
- Grebely, J., Robaeys, G., Bruggmann, P., Aghemo, A., Backmund, M., Bruneau, J., Byrne, J., Dalgard, O., Feld, J. J., Hellard, M., Hickman, M., Kautz, A., Litwin, A., Lloyd, A. R., Mauss, S., Prins, M., Swan, T., Schaefer, M., Taylor, L. E., & Dore, G. J. (2015). Recommendations for the management of hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2015.07.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
